Rm Clinical Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.24 M
- Company Age 36 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 0.85 M
- Revenue Growth -14.32%
- Profit Growth -987.45%
- Ebitda -275.65%
- Net Worth -9.84%
- Total Assets -2.36%
About Rm Clinical Laboratories
Rm Clinical Laboratories Private Limited (RCLPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 March 1988 and has a history of 36 years and ten months. Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.24 M.
The company has closed loans amounting to ₹0.85 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Partha Roy, Amiya Basu, Rita Bose, and Four other members serve as directors at the Company.
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85195WB1988PTC044052
- Company No.
044052
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Mar 1988
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Rm Clinical Laboratories?
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Udit Roy  | Director | 14-May-2013 | Current |
| Partha Roy | Director | 29-Mar-1988 | Current |
| Amiya Basu | Director | 29-Mar-1988 | Current |
| Rita Bose | Director | 11-Apr-2007 | Current |
| Runa Roychowdhury | Director | 01-Aug-1990 | Current |
| Gongotri Bose | Director | 20-Jun-2011 | Current |
Financial Performance of Rm Clinical Laboratories.
Rm Clinical Laboratories Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 14.32% decrease. The company also saw a substantial fall in profitability, with a 987.45% decrease in profit. The company's net worth dipped by a decrease of 9.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rm Clinical Laboratories?
In 2023, Rm Clinical Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹0.85 M
Charges Breakdown by Lending Institutions
- Bank Of India : 0.09 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jun 2008 | Bank Of India | ₹0.55 M | Satisfied |
| 23 Aug 2005 | Bank Of India | ₹0.30 M | Satisfied |
How Many Employees Work at Rm Clinical Laboratories?
Rm Clinical Laboratories has a workforce of 3 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rm Clinical Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rm Clinical Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
